Tagarno A/S

Tagarno A/S specializes in devices for film production workflows, specifically the 35/CD CineConverter, which converts and processes 35mm film into digital cinematic formats. This device supports post-production tasks in filmmaking, though it is not a traditional medical device. Its classification under FDA regulations reflects its role in specialized industrial workflows rather than direct patient care.

Tagarno A/S is based in the United States, which means its devices fall under FDA jurisdiction. Since the 35/CD CineConverter is classified as a Class II device, it requires premarket notification (510(k)) to demonstrate substantial equivalence to a legally marketed predicate device before commercial distribution. The FDA’s oversight applies to ensure safety and performance in its intended use, even if the device is not directly medical.

Tagarno A/S’s devices, including the 35/CD CineConverter, are listed in the FDA’s 510(k) premarket notification database. This registry confirms that the device has undergone the required regulatory review process to establish compliance with FDA standards for Class II devices. The listing serves as public documentation of the device’s authorization pathway.

The 35/CD CineConverter is classified as a Class II device by the FDA. This classification is based on its intended use—facilitating film-to-digital conversion in post-production—rather than direct patient interaction. Class II devices typically require 510(k) premarket notifications to demonstrate they meet performance criteria and are substantially equivalent to existing authorized devices, ensuring they pose minimal risk while maintaining efficacy in their specialized application.